SECTORS

Thirteen first-class sector entities covering the commercial space economy — from mature launch and broadband through frontier R&D categories. Each card shows operator count, SAI sub-index score, sector ARI median, and cumulative government grant capture. Click any sector for operators, SAI composition, and risk distribution.

Jump toAll · 13Commercial · 3Early Commercial · 3Pre-Commercial · 4R&D · 3
Most activeEO & GEOINT0D · 51opLaunch0D · 16opBroadband & DTC0D · 14opISAM1D · 9opSpace Mining0D · 11op
Commercial
3 sectors · Mature commercial markets with multi-operator scale.
LaunchCommercial

Launch & Reusable Rockets

16
Operators
64.5
SAI SUB
ARI Med
$9.8B
Gov $

Commercial and government services that deliver payloads from Earth into suborbital trajectories or orbit using expendable, partially reusable, and fully reusable rockets. Providers generate revenue through per-launch contracts, rideshare manifests, and multi-mission agreements for satellite operators, defense agencies, crew transport, and cargo resupply. The sector is characterized by a mature commercial market dominated by reusable-booster economics, where price per kilogram, cadence, and reliability curves are the primary competitive axes. Vehicles span small, medium, heavy, and super-heavy lift classes across multiple national launch ecosystems.

Broadband & DTCCommercial

Satellite Broadband & Direct-to-Cell

14
Operators
54.6
SAI SUB
69.2
ARI Med
$16.8M
Gov $

Satellite systems in low, medium, and geostationary Earth orbit that deliver broadband internet and, increasingly, cellular connectivity directly to unmodified mobile handsets. Revenue is generated through consumer and enterprise subscriptions, maritime and aviation service contracts, government connectivity agreements, and wholesale carrier partnerships for direct-to-device services. The sector is distinguished from legacy geostationary fixed-satellite services by large low-orbit constellations optimized for low latency and ubiquitous coverage, and is a commercial market with several operators at scale and multiple pre-revenue entrants in active deployment.

EO & GEOINTCommercial

Earth Observation & Geospatial Intelligence

51
Operators
55.8
SAI SUB
67.0
ARI Med
$51.9B
Gov $

Satellites and downstream analytics services that collect and process imagery and sensor data of the Earth using optical, synthetic-aperture radar, hyperspectral, and radio-frequency payloads. Operators generate revenue through imagery tasking fees, data subscriptions, analytics licensing, and government intelligence contracts for defense, civil, insurance, agriculture, and environmental monitoring customers. The sector is a commercial market in which hardware revenue is increasingly secondary to data and analytics products, with defense and geospatial-intelligence demand forming a structurally large share of total spending across North American, European, and Asian programs.

Early Commercial
3 sectors · Revenue-generating operators, still scaling.
ISAMEarly Commercial

In-Space Servicing, Assembly & Manufacturing (ISAM)

9
Operators
48.5
SAI SUB
ARI Med
$99.4M
Gov $

On-orbit activities that service, refuel, inspect, repair, relocate, and extend the operational life of existing spacecraft, as well as the robotic assembly and manufacture of structures in space. Revenue is generated primarily from government demonstration contracts, debris-remediation awards, and early commercial life-extension agreements with satellite operators, with refueling and assembly services beginning to enter initial commercial offerings. The sector is early commercial: life-extension services account for the largest captured revenue, while refueling, assembly, and in-space manufacturing remain in demonstration and technology-maturation phases.

Stations & TourismEarly Commercial

Commercial Space Stations & Tourism

7
Operators
28.6
SAI SUB
55.8
ARI Med
$38.5B
Gov $

Privately developed crewed orbital habitats, modular commercial space stations intended as successors to the International Space Station, and suborbital and orbital human spaceflight services operated for paying customers. Revenue is generated through private-astronaut mission bookings, ticketed suborbital flights, government contracts funding commercial low-Earth-orbit destinations, and hosted-payload and in-orbit research fees. The sector is early commercial, transitioning from individual private missions and short suborbital flights toward continuous commercial station operations, with execution contingent on habitat certification and sustained government anchor demand.

Hypersonic TestingEarly Commercial

Hypersonic Flight Testing-as-a-Service

2
Operators
54.2
SAI SUB
ARI Med
Gov $

Commercial provision of flight testbeds that carry payloads, sensors, and materials at speeds above Mach 5, delivering flight-relevant test environments for hypersonic weapons, vehicles, and thermal-protection systems. Revenue is generated through per-flight test contracts and multi-mission indefinite-delivery agreements with defense agencies, national laboratories, and research institutions. The sector is early commercial, built primarily on government test-range demand and programs that procure hypersonic test opportunities as a service; the business model is distinct from launch in that the objective is flight environment exposure rather than orbital insertion.

Pre-Commercial
4 sectors · Demonstration phase; revenue not yet sustained.
Pharma MicrogravityPre-Commercial

Pharmaceutical Manufacturing in Microgravity

2
Operators
21.3
SAI SUB
ARI Med
$14.1M
Gov $

Use of the microgravity environment in orbit to grow protein crystals and process active pharmaceutical ingredients with structural uniformity and particle characteristics that are difficult or impossible to achieve in terrestrial gravity. Intended revenue sources are licensing of microgravity-optimized formulations to pharmaceutical companies, contract manufacturing of specialty APIs, and direct sale of returned product. The sector is pre-commercial, with revenue currently derived from research payload contracts and venture funding rather than approved drug products, pending regulatory validation and a first in-space-derived API reaching market.

Orbital Data CentersPre-Commercial

Orbital Data Centers

3
Operators
65.5
SAI SUB
ARI Med
Gov $

Compute and storage infrastructure deployed on orbit that processes data at its source in space and offers solar-powered capacity outside the terrestrial power, water, and land constraints that bound conventional data centers. Intended revenue sources are edge-processing fees for Earth-observation operators, on-orbit hosting for government and enterprise workloads, and subscription compute capacity for artificial-intelligence and analytics customers. The sector is pre-commercial, with activity consisting of small demonstration payloads and concept studies rather than production services, and revenue dominated by early seed and government-study funding.

SBSPPre-Commercial

Space-Based Solar Power

0
Operators
53.5
SAI SUB
ARI Med
Gov $

Systems that collect solar energy in orbit, where sunlight is nearly continuous and unattenuated by atmosphere, and transmit that energy to receivers on Earth or to other spacecraft using microwave or laser power beaming. Intended revenue sources are long-term baseload-power offtake agreements with utilities and governments, and power-beaming services to remote terrestrial sites, disaster-relief operations, and other space assets. The sector is pre-commercial and policy-dependent, with funding concentrated in government-committed programs and university research rather than revenue-generating operations, and no commercial utility power delivered to date.

Space MiningPre-Commercial

Asteroid & Lunar Resource Extraction

11
Operators
57.5
SAI SUB
ARI Med
$20.3B
Gov $

Prospecting, extraction, processing, and utilization of water, regolith, metals, and volatiles on the Moon, asteroids, and other non-terrestrial bodies, including in-situ resource utilization for propellant, life support, and construction materials. Near-term revenue is generated from lunar lander and payload-delivery services contracted under government programs rather than from resources themselves, which have not been commercially extracted or sold. The sector is pre-commercial, with captured revenue concentrated in lander services under lunar-payload-services contracts and prospecting-instrument payloads funded by space agencies.

R&D
3 sectors · Research payloads and technology-maturation work.
ZBLAN FiberR&D

ZBLAN Optical Fiber

2
Operators
64.5
SAI (PROJ)
ARI Med
Gov $

On-orbit drawing of heavy-metal fluoride optical fiber, a glass composition that in microgravity can avoid crystalline defects formed during terrestrial production and achieve attenuation substantially lower than silica fiber. Intended revenue sources are sale of specialty fiber for telecommunications repeater spans, mid-infrared sensing, and high-power laser systems where performance commands a premium over conventional fiber. The sector is pre-commercial and remains in the research-and-development phase, with activity limited to technology-demonstration payloads and small research contracts rather than sustained commercial fiber production.

Space Semis & AlloysR&D

Space-Manufactured Semiconductors & Advanced Alloys

2
Operators
SAI SUB
ARI Med
Gov $

On-orbit production of semiconductor crystals, specialty wafers, and advanced metal alloys that exploit microgravity to suppress buoyancy-driven convection and sedimentation, enabling compositions, purities, and microstructures difficult to obtain on Earth. Intended revenue sources are sale of returned high-value materials to semiconductor, aerospace, and defense customers, and contract processing for specialty metallurgy. The sector is pre-commercial and in the research-and-development phase, with activity confined to small demonstration missions, research payloads, and government-supported development of returnable free-flying manufacturing platforms.

BioprintingR&D

Bioprinting & Tissue Engineering

1
Operators
22.7
SAI (PROJ)
ARI Med
Gov $

Use of the microgravity environment in orbit to print and culture three-dimensional human tissues, organoids, and related biological constructs, which on Earth tend to collapse under their own weight before vascularization or cell differentiation is complete. Intended revenue sources are research-services contracts, licensing of tissue-engineering protocols, and eventual supply of bioprinted constructs for drug testing and regenerative medicine. The sector is pre-commercial and in the research-and-development phase, with activity confined to station-based research facilities and government-funded biology payloads.

SPACE FINANCE INTELLIGENCE
Sector analysis + deal flow. Every Tuesday at 8 AM ET.